T40.721

Clinical Causes: Use of synthetic cannabinoid products marketed as legal or safe alternatives to marijuana Unintentional ingestion of contaminated or mislabeled substances Consumption of products containing synthetic cannabinoids without proper knowledge or guidance Availability of these substances in forms such as sprays, liquids, or herbal blends designed to be smoked or vaporized Misidentification of synthetic products as natural herbs or unobjectionable substances

Key Symptoms: Severe agitation or confusion Hallucinations or paranoid behaviors Rapid heartbeat (tachycardia) High blood pressure (hypertension) Nausea and vomiting Chest pain or tightness Dizziness or fainting Seizures in extreme cases Loss of consciousness or coma Muscle weakness or tremors

Diagnosis Path: Diagnosis of synthetic cannabinoid poisoning involves a combination of medical history review, physical examination, and laboratory testing. Given that standard drug screens may not detect synthetic cannabinoids, healthcare providers might rely on specialized tests, including urine, blood, or tissue analyses, that are capable of identifying these substances. Additionally, clinicians assess symptoms and exposure history to make an accurate diagnosis. Prompt recognition is crucial for effective management and intervention.

Treatment Protocols: Treatment primarily focuses on supportive care tailored to the symptoms presented. Medical professionals monitor vital signs closely and provide interventions such as IV fluids for dehydration, medications to manage agitation or seizures, and mental health support. In cases of severe toxicity, hospitalization may be required. It's important to avoid further exposure by removing any remaining synthetic substances and seeking emergency medical care as needed. Long-term medical and psychological follow-up may be necessary for recovery and to address any underlying substance use issues.